Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-30 Purchase | 2024-11-01 4:15 pm | enGene Holdings Inc. | ENGN | Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner | 561,797 | $8.9 | $4,999,993 | 6,798,362 (Indirect Direct) | View |
| 2023-12-27 Purchase | 2024-10-18 4:15 pm | enGene Holdings Inc. | ENGN | Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner | 470,633 | $6.4013 | $3,012,674 | 6,236,565 (Indirect Direct) | View |
| 2024-09-27 Purchase | 2024-10-01 08:02 am | enGene Holdings Inc. | ENGN | Cooper Ronald Harold Wilfred Chief Executive Officer | 10,000 | $5.7 | $57,000 | 10,000 (Direct) | View |
| 2024-04-18 Sale | 2024-04-22 5:22 pm | enGene Holdings Inc. | ENGN | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC 10% Owner | 52,529 | $15 | $787,981 | 3,036,153 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-21 Option Award | 2024-10-22 4:08 pm | N/A 2034-10-21 | enGene Holdings Inc. | ENGN | CHEUNG ANTHONY TZEYEW Chief Scientific Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-10-21 Option Award | 2024-10-22 4:07 pm | N/A 2034-10-21 | enGene Holdings Inc. | ENGN | Connolly Joan Chief Technology Officer | 210,000 | $0 | 210,000 (Direct) | View |
| 2024-07-24 Option Award | 2024-07-25 8:32 pm | N/A 2034-07-24 | enGene Holdings Inc. | ENGN | Pruthi Raj Som Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |
Ownership | 2024-07-25 8:30 pm | N/A 2034-04-22 | enGene Holdings Inc. | ENGN | Pruthi Raj Som Chief Medical Officer | 0 | $0 | 125,000 (Direct) | View |
| 2024-07-22 Option Award | 2024-07-24 6:26 pm | N/A 2034-07-22 | enGene Holdings Inc. | ENGN | Cooper Ronald Harold Wilfred Chief Executive Officer | 1,250,000 | $0 | 1,250,000 (Direct) | View |
| 2024-06-15 Option Award | 2024-06-18 4:09 pm | N/A 2034-06-15 | enGene Holdings Inc. | ENGN | Zoth Lota S. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-06-15 Option Award | 2024-06-18 4:08 pm | N/A 2034-06-15 | enGene Holdings Inc. | ENGN | HASTINGS PAUL J Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-06-15 Option Award | 2024-06-18 4:08 pm | N/A 2034-06-15 | enGene Holdings Inc. | ENGN | Joustra Wouter Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-06-15 Option Award | 2024-06-18 4:06 pm | N/A 2034-06-15 | enGene Holdings Inc. | ENGN | Glickman Richard M Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-06-15 Option Award | 2024-06-18 4:05 pm | N/A 2034-06-15 | enGene Holdings Inc. | ENGN | Bos Jasper Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-06-15 Option Award | 2024-06-18 4:04 pm | N/A 2034-06-15 | enGene Holdings Inc. | ENGN | BRUNK GERALD A Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-05-28 Exercise | 2024-05-29 6:12 pm | N/A N/A | enGene Holdings Inc. | ENGN | Glickman Richard M Director | 120 | $0.89 | 24,675 (Direct) | View |
| 2024-05-28 Exercise | 2024-05-29 6:12 pm | N/A N/A | enGene Holdings Inc. | ENGN | Glickman Richard M Director | 120 | $0 | 24,675 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 4:01 pm | N/A 2034-03-21 | enGene Holdings Inc. | ENGN | Zoth Lota S. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 4:42 pm | N/A N/A | enGene Holdings Inc. | ENGN | CHEUNG ANTHONY TZEYEW Chief Technology Officer | 52,940 | $0.89 | 102,873 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 4:42 pm | N/A N/A | enGene Holdings Inc. | ENGN | CHEUNG ANTHONY TZEYEW Chief Technology Officer | 52,940 | $0 | 102,873 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-19 4:05 pm | N/A 2034-03-15 | enGene Holdings Inc. | ENGN | Giguere Lee Chief Legal Ofc. and Corp Secy | 225,000 | $0 | 225,000 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-21 4:20 pm | N/A N/A | enGene Holdings Inc. | ENGN | BRUNK GERALD A Director 10% Owner | 800,000 | $10 | 2,855,648 (Indirect) | View |
| 2024-02-20 Option Award | 2024-02-21 4:20 pm | N/A N/A | enGene Holdings Inc. | ENGN | Lumira Capital Investment Management Inc. 10% Owner | 800,000 | $10 | 2,855,648 (Indirect) | View |
| 2023-11-30 Option Award | 2023-12-04 5:55 pm | N/A 2033-11-30 | enGene Holdings Inc. | ENGN | BRYCE RICHARD PAUL Chief Medical Officer | 153,000 | $0 | 153,000 (Direct) | View |
| 2023-11-30 Option Award | 2023-12-04 5:52 pm | N/A 2033-11-30 | enGene Holdings Inc. | ENGN | Daws D. Ryan Chief Financial Officer | 232,000 | $0 | 232,000 (Direct) | View |
Ownership | 2023-11-13 4:48 pm | N/A N/A | enGene Holdings Inc. | ENGN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 0 | $0 | 3,154,418 (Direct) | View |
Ownership | 2023-11-13 4:00 pm | N/A N/A | enGene Holdings Inc. | ENGN | Forbion Capital Fund III Cooperatief U.A. Forbion III Management B.V. 10% Owner | 0 | $0 | 3,369,811 (Direct) | View |
Ownership | 2023-11-07 6:08 pm | N/A N/A | enGene Holdings Inc. | ENGN | Lumira Capital Investment Management Inc. 10% Owner | 0 | $0 | 3,381,853 (Indirect) | View |
| 2023-10-31 Other | 2023-11-02 5:29 pm | N/A N/A | enGene Holdings Inc. | ENGN | Forbion Growth Sponsor FEAC I B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner | 3,397,223 | $0 | 11,347,693 (Indirect) | View |
Ownership | 2023-11-02 5:26 pm | N/A N/A | enGene Holdings Inc. | ENGN | Forbion Growth Sponsor FEAC I B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner | 0 | $0 | 4,771,781 (Indirect) | View |
| 2023-02-18 Option Award | 2023-11-02 4:10 pm | N/A 2033-02-18 | enGene Holdings Inc. | ENGN | Nichols Alexander Julian Pres. & Chief Operating Ofc. | 279,859 | $0 | 279,859 (Direct) | View |
| 2013-12-04 Option Award | 2023-11-02 4:10 pm | N/A 2023-12-04 | enGene Holdings Inc. | ENGN | CHEUNG ANTHONY TZEYEW Chief Technology Officer | 535,442 | $0 | 535,442 (Direct) | View |
| 2018-07-09 Option Award | 2023-11-02 4:09 pm | N/A 2028-07-09 | enGene Holdings Inc. | ENGN | Hanson Jason David Chief Executive Officer | 1,216,266 | $0 | 1,216,266 (Direct) | View |
| 2022-03-18 Option Award | 2023-11-02 4:09 pm | N/A 2032-03-18 | enGene Holdings Inc. | ENGN | Sullivan James Crowley Chief Scientific Officer | 207,410 | $0 | 207,410 (Direct) | View |
| 2013-12-04 Option Award | 2023-11-02 4:08 pm | N/A 2023-12-04 | enGene Holdings Inc. | ENGN | Glickman Richard M Director | 90,436 | $0 | 90,436 (Direct) | View |